Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system, doxazosin standard, and placebo in patients with benign prostatic hyperplasia.

Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system, doxazosin standard, and placebo in patients with benign prostatic hyperplasia.

Item
http://www.wikidata.org/entity/Q39425971
Comparative effectiveness of oral drug therapies for lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and network meta-analysisClinical ease of using doxazosin in BPH patients with and without hypertension.A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia.Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects.Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS)After ALLHAT: doxazosin for the treatment of benign prostatic hyperplasia.Treatment of benign prostatic hyperplasia in hypertensive men.Doxazosin in the treatment of benign prostatic hypertrophy: an update.A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasiaPlacebo Medication and Sham Surgery Responses in Benign Prostatic Hyperplasia Treatments: Implications for Clinical Trials.A randomised, double-blind study comparing the efficacy and tolerability of controlled-release doxazosin and tamsulosin in the treatment of benign prostatic hyperplasia in Brazil.Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study.Effectiveness of doxazosin on erectile dysfunction in patients with lower urinary tract symptoms.A Randomized, Open-Label, Comparative Study of Efficacy and Safety of Tolterodine Combined with Tamsulosin or Doxazosin in Patients with Benign Prostatic Hyperplasia.The impact of metabolic syndrome on the responsiveness to α1-blocker in men with BPH/LUTS.The clinical efficacy and tolerability of doxazosin standard and gastrointestinal therapeutic system for benign prostatic hyperplasia.Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension.
P2860

Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system, doxazosin standard, and placebo in patients with benign prostatic hyperplasia.

Item
http://www.wikidata.org/entity/Q39425971
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Double-blind trial of the effi ...... benign prostatic hyperplasia.
@en
Double-blind trial of the effi ...... benign prostatic hyperplasia.
@nl
type
label
Double-blind trial of the effi ...... benign prostatic hyperplasia.
@en
Double-blind trial of the effi ...... benign prostatic hyperplasia.
@nl
prefLabel
Double-blind trial of the effi ...... benign prostatic hyperplasia.
@en
Double-blind trial of the effi ...... benign prostatic hyperplasia.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Double-blind trial of the effi ...... benign prostatic hyperplasia.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921